Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy
4 affiliations
- 1Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, Poland
- 2Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, Poland
- 3Department of Food and Nutrition, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland
- 4Department of Medical Chemistry, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland
Abstract
Epigenetic dysregulation constitutes a fundamental molecular hallmark of oncogenesis, arising from aberrant alterations in chromatin architecture and transcriptional regulation that disrupt cellular differentiation, sustain malignant phenotypes, promote therapeutic resistance, and facilitate tumor initiation and progression. Among the principal epigenetic mechanisms, histone acetylation is dynamically regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), making these enzymes attractive targets for pharmacological intervention. Although several synthetic epigenetic drugs have entered clinical practice, their therapeutic utility may be constrained by limited selectivity, toxicity, and adaptive resistance, prompting the continued investigation of structurally diverse natural compounds. The review examines comparatively underexplored plant-derived phytochemicals with reported or proposed HAT- and/or HDAC-modulatory properties, focusing on parthenolide, anacardic acid, formononetin, plumbagin, and allicin and its derivatives, including S-allylmercaptocysteine (SAMC). The available evidence indicates that these compounds can influence epigenetic processes through distinct, pleiotropic, mechanisms, potentially affecting cellular proliferation, apoptosis, differentiation, and responses to anticancer treatment. Collectively, these findings support the further investigation of cryptic plant-derived HAT/HDAC modulators as candidate epigenetic adjuvants, while underscoring the need for rigorous mechanistic validation, pharmacokinetic characterization, and translational assessment.
Related
- Dynamic Modulation of Neural Cell Identity Maintenance via Lysine Acetyltransferase Type 3 Protein Targeted Degradation
- Histone deacetylase inhibition induces an antitumor IRF8-dependent trained immunity-like status in macrophages.
- N-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA
- Plant-Derived Saponin and Polysaccharide Vaccine Adjuvants: Structure-Activity Relationships and Immune-Enhancement Strategies.
- Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
BibTeX
@article{okon2026beyond,
title = {{Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy}},
author = {Estera Okoń and Agata Jarząb and Wirginia Kukula-Koch and Joanna Tokarczyk and Wojciech Koch and Anna Boguszewska-Czubara and Anna Wawruszak},
journal = {Cells},
year = {2026},
month = nov,
doi = {10.3390/cells15212035},
url = {https://www.mdpi.com/2073-4409/15/21/2035},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy
AU - Estera Okoń
AU - Agata Jarząb
AU - Wirginia Kukula-Koch
AU - Joanna Tokarczyk
AU - Wojciech Koch
AU - Anna Boguszewska-Czubara
AU - Anna Wawruszak
PY - 2026
DA - 2026/11/08
JO - Cells
DO - 10.3390/cells15212035
UR - https://www.mdpi.com/2073-4409/15/21/2035
AB - Epigenetic dysregulation constitutes a fundamental molecular hallmark of oncogenesis, arising from aberrant alterations in chromatin architecture and transcriptional regulation that disrupt cellular differentiation, sustain malignant phenotypes, promote therapeutic resistance, and facilitate tumor initiation and progression. Among the principal epigenetic mechanisms, histone acetylation is dynamically regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), making these enzymes attractive targets for pharmacological intervention. Although several synthetic epigenetic drugs have entered clinical practice, their therapeutic utility may be constrained by limited selectivity, toxicity, and adaptive resistance, prompting the continued investigation of structurally diverse natural compounds. The review examines comparatively underexplored plant-derived phytochemicals with reported or proposed HAT- and/or HDAC-modulatory properties, focusing on parthenolide, anacardic acid, formononetin, plumbagin, and allicin and its derivatives, including S-allylmercaptocysteine (SAMC). The available evidence indicates that these compounds can influence epigenetic processes through distinct, pleiotropic, mechanisms, potentially affecting cellular proliferation, apoptosis, differentiation, and responses to anticancer treatment. Collectively, these findings support the further investigation of cryptic plant-derived HAT/HDAC modulators as candidate epigenetic adjuvants, while underscoring the need for rigorous mechanistic validation, pharmacokinetic characterization, and translational assessment.
SN - 2073-4409
ER -